Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Tofacitinib helped a 21-year-old regrow hair after alopecia totalis.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Disrupting the Sox21 gene in mice causes hair loss and regrowth cycles.

The model showed that randomness accurately describes individual hair growth cycles and that synchronization can cause large fluctuations not seen in humans.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

AMT® is effective and safe for early-stage knee osteoarthritis.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Activins and follistatins, part of the TGFβ family, are crucial for hair follicle development and skin health, affecting growth, repair, and the hair cycle.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

The hair regrowth tonic effectively increased hair count and was safe for treating male pattern baldness.

Corticosteroid therapy for alopecia areata can cause severe hip bone damage.

Azathioprine is the most continued treatment for chronic alopecia areata over a year, often with added low-dose prednisolone.

Cirsium japonicum var. spinossimum seeds may help reduce inflammation and fight cancer.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Upadacitinib successfully treated a child's severe skin and hair loss issues.

The study created 3D-printed pills that effectively release a hair loss treatment drug over 24 hours.

Fetuin A levels are higher in PCOS patients, while asprosin levels show no difference.

Niosomes improve aminexil's effectiveness in preventing hair loss without needing propylene glycol.

PAD enzymes play a key role in hair growth and structure.

The document reports three sisters with Woodhouse-Sakati syndrome showing typical symptoms and unusual gynecological anomalies.

N‐AOHPA is a promising alternative to traditional surfactants for better hair conditioning.